| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/26/2004 | US20040038929 Drugs against articular failure |
| 02/26/2004 | US20040038907 For healing wounds/tissue repair |
| 02/26/2004 | US20040038889 Fumaric acid amides |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038869 Inhibitors of complement activation, their preparation and use |
| 02/26/2004 | US20040038402 Gene therapy; for production of transgenic animal models |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038293 Antibodies to human cd154 |
| 02/26/2004 | US20040038292 Comprises nucleotide sequences which code wound healing proteins for treatment and prevention of scarring, fibrosis, restenosis post angioplasty, psoriasis, benign prostatic hyperplasia, glaucoma and nervous suystem disorders |
| 02/26/2004 | US20040038265 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040038230 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038223 Comprise polypeptide for diagnosis, prevention and treatment of cardiomyopathy, atherosclerosis, hypertension, cancer, diabetes and nervous system disorders |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040037876 Use or r-arylpropionic acids for producing medicaments for treating illnesses with a rheumatic nature |
| 02/26/2004 | US20040037841 Nucleic acid sequences that are expressed in chondrocytes from fetal, normal, mild osteoarthritic, moderate osteoarthritic, marked and osteoarthritic |
| 02/26/2004 | US20040037827 Administering antibody to integrin |
| 02/26/2004 | CA2497304A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | CA2496419A1 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | CA2495383A1 Fused benzene derivative and use |
| 02/26/2004 | CA2494811A1 Therapeutic use of fused bicyclic or tricyclic amino acids |
| 02/26/2004 | CA2494546A1 Substituted glycine derivatives for use as medicaments |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1391426A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 02/25/2004 | EP1391211A1 Chondrogenesis promoters |
| 02/25/2004 | EP1391199A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 02/25/2004 | EP1391197A1 Process for preparation of compositions with a high content in avarol and their use |
| 02/25/2004 | EP1390543A2 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 02/25/2004 | EP1390508A2 A retinoic acid metabolizing cytochrome p450 |
| 02/25/2004 | EP1390409A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 02/25/2004 | EP1390408A1 A molecular marker |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390385A2 Nucleic acid based modulation of female reproductive diseases and conditions |
| 02/25/2004 | EP1390383A1 Antisense permeation enhancers |
| 02/25/2004 | EP1390363A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| 02/25/2004 | EP1390362A1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 02/25/2004 | EP1390357A2 Anti-thrombotic compounds, production and use thereof as medicaments |
| 02/25/2004 | EP1390353A1 Triazole-derived kinase inhibitors and uses thereof |
| 02/25/2004 | EP1390348A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors |
| 02/25/2004 | EP1390081A2 Therapeutic and diagnostic compounds, compositions, and methods |
| 02/25/2004 | EP1390077A2 Treatment and diagnosis of macrophage mediated disease |
| 02/25/2004 | EP1390062A2 Modulators of elastase inhibitor secretion |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP1390025A1 Coenzyme q and eicosapentaenoic acid (epa) |
| 02/25/2004 | EP1390018A1 A pharmaceutical tablet having a high api content |
| 02/25/2004 | EP1390013A2 Therapeutic treatments using the direct application of antimicrobial metal compositions |
| 02/25/2004 | EP1390011A2 Control of compactability through crystallization |
| 02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 02/25/2004 | EP1210326B1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1478087A Indolylmaleimide derivatives as protein kinase C inibitors |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1477979A Tissue equivalant for transplantation and process for producing the same |
| 02/25/2004 | CN1477976A Combination of GABA agonists and aldose reductase inhibitors |
| 02/25/2004 | CN1477968A Methods for treating rheumatic diseases using soluble CTLA4 molecule |
| 02/25/2004 | CN1477967A Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 02/25/2004 | CN1477966A Shark meat extract |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1476859A Bone-strengthening kidney-supplementing pill |
| 02/25/2004 | CN1476856A Qianghua Poyutongluo powder preparation for curing osteodynia and its preparation method |
| 02/25/2004 | CN1476853A Medicine for curing hyperasteogeny and its preparation process |
| 02/25/2004 | CN1476847A Chinese medicine oil preparation for promoting blood circulation |
| 02/25/2004 | CN1139400C Medicine for treating arthritis and bone injury disease |
| 02/25/2004 | CN1139397C Plaster for treating hyperosteogeny and osteoarthropathy and its producing method |
| 02/25/2004 | CN1139393C Externally applied plaster and its preparing method |
| 02/25/2004 | CN1139392C Quick-acting bone-setting powder medicine |
| 02/24/2004 | US6696601 Bone disorders |
| 02/24/2004 | US6696578 Difuro-8-pyrone for use in the diagnosis, detection and treatment of tumors, diabetes, cardiovascular and bone disorders |
| 02/24/2004 | US6696567 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2004 | US6696566 Selective p38 kinase inhibitors relative to cyclin-dependent kinases and tyrosine kinases |
| 02/24/2004 | US6696471 Aminopyrrole compounds |
| 02/24/2004 | US6696470 Pyridylthiophene compounds |
| 02/24/2004 | US6696467 Quinoline derivatives |
| 02/24/2004 | US6696464 Triazolo-pyridines anti-inflammatory compounds |
| 02/24/2004 | US6696458 Having x-ray powder diffraction pattern with lines at degrees 2 theta values 6.7, 12.5, 14.0 and 23.9 for cu k alpha radiation of wavelength 1.5406 angstrom |
| 02/24/2004 | US6696454 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696449 Control degradation of conencting tissue; cardiovascular disorders |
| 02/24/2004 | US6696447 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 02/24/2004 | US6696446 Benzoylpyridazines, their preparation and use |
| 02/24/2004 | US6696443 Piperidine/piperazine-type inhibitors of p38 kinase |
| 02/24/2004 | US6696437 Polymerase inhibitors comprising heterocyclic amides such as 2-pyridin-2-ylbenzimidazole-4-carboxamide, used for prophylaxis of neurodegenerative disorders, damage to hearts or brains, and as anticarcinogenic agents |
| 02/24/2004 | US6696434 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 02/24/2004 | US6696429 Especially due to osteoarthrosis, osteochondrosis, navicular disease or enthesopathy of the bony insertions of the tendons, of the ligaments, or of the aponeurosis, particularly in horses |
| 02/24/2004 | CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| 02/19/2004 | WO2004014932A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 02/19/2004 | WO2004014921A1 5,6-fused uracil derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014920A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/19/2004 | WO2004014911A1 Phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2004014903A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 02/19/2004 | WO2004014892A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014880A1 Chromone derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014861A1 4-substituted-quinoline-8-carboxylic amide derivatives and pharmacologically acceptable addition salts thereof |
| 02/19/2004 | WO2004014859A2 Process for preparing quinolin antibiotic intermediates |
| 02/19/2004 | WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014825A1 Cannabinoid receptor ligands |